AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
Current status of HER2 testing - Caught between a rock and a hard place
Authors: Schnitt, SJ Jacobs, TW
Citation: Sj. Schnitt et Tw. Jacobs, Current status of HER2 testing - Caught between a rock and a hard place, AM J CLIN P, 116(6), 2001, pp. 806-810
Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis
Authors: Lehr, HA Jacobs, TW Yaziji, H Schnitt, SJ Gown, AM
Citation: Ha. Lehr et al., Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis, AM J CLIN P, 115(6), 2001, pp. 814-822
Pathologic features of breast cancers in women with previous benign breastdisease
Authors: Jacobs, TW Byrne, C Colditz, G Connolly, JL Schnitt, SJ
Citation: Tw. Jacobs et al., Pathologic features of breast cancers in women with previous benign breastdisease, AM J CLIN P, 115(3), 2001, pp. 362-369
Breast cancer in the 21st century: Neu opportunities and neu challenges
Authors: Schnitt, SJ
Citation: Sj. Schnitt, Breast cancer in the 21st century: Neu opportunities and neu challenges, MOD PATHOL, 14(3), 2001, pp. 213-218
Carcinomas in situ of the breast with indeterminate features - Role of E-cadherin staining in categorization
Authors: Jacobs, TW Pliss, N Kouria, G Schnitt, SJ
Citation: Tw. Jacobs et al., Carcinomas in situ of the breast with indeterminate features - Role of E-cadherin staining in categorization, AM J SURG P, 25(2), 2001, pp. 229-236
Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: Results from the radiologic diagnostic oncology group V
Authors: Pisano, ED Fajardo, LL Caudry, DJ Sneige, N Frable, WJ Berg, WA Tocino, I Schnitt, SJ Connolly, JL Gatsonis, CA McNeil, BJ
Citation: Ed. Pisano et al., Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: Results from the radiologic diagnostic oncology group V, RADIOLOGY, 219(3), 2001, pp. 785-792
Her-2/neu by immunohistochemistry: Where is the threshold? Reply
Authors: Jacobs, TW Gown, AM Yaziji, H Barnes, MJ Schnitt, SJ
Citation: Tw. Jacobs et al., Her-2/neu by immunohistochemistry: Where is the threshold? Reply, AM J CLIN P, 114(5), 2000, pp. 819-819
HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry - A study of interlaboratory agreement
Authors: Jacobs, TW Gown, AM Yaziji, H Barnes, MJ Schnitt, SJ
Citation: Tw. Jacobs et al., HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry - A study of interlaboratory agreement, AM J CLIN P, 113(2), 2000, pp. 251-258
Correspondence re: Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol 1999;12 : 941-5
Authors: Schnitt, SJ
Citation: Sj. Schnitt, Correspondence re: Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol 1999;12 : 941-5, MOD PATHOL, 13(12), 2000, pp. 1333-1333
Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence
Authors: Park, CC Mitsumori, M Nixon, A Recht, A Connolly, J Gelman, R Silver, B Hetelekidis, S Abner, A Harris, JR Schnitt, SJ
Citation: Cc. Park et al., Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: Influence of margin status and systemic therapy on local recurrence, J CL ONCOL, 18(8), 2000, pp. 1668-1675
Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy
Authors: Galper, S Recht, A Silver, B Bernardo, MVP Gelman, R Wong, J Schnitt, SJ Connolly, JL Harris, JR
Citation: S. Galper et al., Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy, INT J RAD O, 48(1), 2000, pp. 125-132
The relationship between lymphatic vessel invasion, tumor size, and pathologic nodal status: Can we predict who can avoid a third field in the absence of axillary dissection?
Authors: Wong, JS O'Neill, A Recht, A Schnitt, SJ Connolly, JL Silver, B Harris, JR
Citation: Js. Wong et al., The relationship between lymphatic vessel invasion, tumor size, and pathologic nodal status: Can we predict who can avoid a third field in the absence of axillary dissection?, INT J RAD O, 48(1), 2000, pp. 133-137
The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer
Authors: Hetelekidis, S Schnitt, SJ Silver, B Manola, J Bornstein, BA Nixon, AJ Recht, A Gelman, R Harris, JR Connolly, JL
Citation: S. Hetelekidis et al., The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer, INT J RAD O, 46(1), 2000, pp. 31-34
The influence of infiltrating lobular carcinoma on the outcome of patientstreated with breast-conserving surgery and radiation therapy
Authors: Peiro, G Bornstein, BA Connolly, JL Gelman, R Hetelekidis, S Nixon, AJ Recht, A Silver, B Harris, JR Schnitt, SJ
Citation: G. Peiro et al., The influence of infiltrating lobular carcinoma on the outcome of patientstreated with breast-conserving surgery and radiation therapy, BREAST CANC, 59(1), 2000, pp. 49-54
Diagnostic accuracy of Tc-99m-sestamibi breast imaging: Multicenter trial results
Authors: Khalkhali, I Villanueva-Meyer, J Edell, SL Connolly, JL Schnitt, SJ Baum, JK Houlihan, MJ Jenkins, RM Haber, SB
Citation: I. Khalkhali et al., Diagnostic accuracy of Tc-99m-sestamibi breast imaging: Multicenter trial results, J NUCL MED, 41(12), 2000, pp. 1973-1979
Treatment selection in ductal carcinoma in situ
Authors: Morrow, M Schnitt, SJ
Citation: M. Morrow et Sj. Schnitt, Treatment selection in ductal carcinoma in situ, J AM MED A, 283(4), 2000, pp. 453-455
Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk
Authors: Byrne, C Connolly, JL Colditz, GA Schnitt, SJ
Citation: C. Byrne et al., Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk, CANCER, 89(10), 2000, pp. 2046-2052
The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy
Authors: Abner, AL Connolly, JL Recht, A Bornstein, B Nixon, A Hetelekidis, S Silver, B Harris, JR Schnitt, SJ
Citation: Al. Abner et al., The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy, CANCER, 88(5), 2000, pp. 1072-1077
Prognostic factors in breast cancer - College of American Pathologists Consensus Statement 1999
Authors: Fitzgibbons, PL Page, DL Weaver, D Thor, AD Allred, C Clark, GM Ruby, SC O'Malley, F Sinpson, LF Connolly, JL Hayes, DF Edge, SB Lichter, A Schnitt, SJ
Citation: Pl. Fitzgibbons et al., Prognostic factors in breast cancer - College of American Pathologists Consensus Statement 1999, ARCH PATH L, 124(7), 2000, pp. 966-978
Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast
Authors: Brown, LF Guidi, AJ Schnitt, SJ Van De Water, L Iruela-Arispe, ML Yeo, TK Tognazzi, K Dvorak, HF
Citation: Lf. Brown et al., Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast, CLIN CANC R, 5(5), 1999, pp. 1041-1056
Association of age and reproductive factors with benign breast tissue composition
Authors: Gertig, DM Stillman, IE Byrne, C Spiegelman, D Schnitt, SJ Connolly, JL Colditz, GA Hunter, DJ
Citation: Dm. Gertig et al., Association of age and reproductive factors with benign breast tissue composition, CANC EPID B, 8(10), 1999, pp. 873-879
Assessment of pathologic prognostic factors in breast core needle biopsies
Authors: Sharifi, S Peterson, MK Baum, AK Raza, S Schnitt, SJ
Citation: S. Sharifi et al., Assessment of pathologic prognostic factors in breast core needle biopsies, MOD PATHOL, 12(10), 1999, pp. 941-945
Lobular carcinoma in situ: Current concepts and controversies
Authors: Schnitt, SJ Morrow, M
Citation: Sj. Schnitt et M. Morrow, Lobular carcinoma in situ: Current concepts and controversies, SEM DIAGN P, 16(3), 1999, pp. 209-223
Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer
Authors: Jacobs, TW Gown, AM Yaziji, H Barnes, MJ Schnitt, SJ
Citation: Tw. Jacobs et al., Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer, J CL ONCOL, 17(7), 1999, pp. 1974-1982
Specificity of HercepTest in determining HER-2/neu status of breast cancers using the united states food and drug administration-approved scoring system
Authors: Jacobs, TW Gown, AM Yaziji, H Barnes, MJ Schnitt, SJ
Citation: Tw. Jacobs et al., Specificity of HercepTest in determining HER-2/neu status of breast cancers using the united states food and drug administration-approved scoring system, J CL ONCOL, 17(7), 1999, pp. 1983-1987
Risultati: 1-25 | 26-34